Hutch News

Hutch News

Stories tagged 'Human Biology'

H. pylori test hints at risk factor for stomach cancer

Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer

Sept. 12, 2018 | By Sabrina Richards / Fred Hutch News Service

A pilot study by Dr. Nina Salama at Fred Hutch hints that carrying a specific strain of H. pylori could be a risk factor for stomach cancer in East Asian patients.

View story >


Path to a targeted treatment for small-cell lung cancer?

Researchers show how common mutation in SCLC makes mouse tumors more vulnerable to certain cancer drugs

Sept. 4, 2018 | By Sabrina Richards / Fred Hutch News Service

Work by Dr. David MacPherson could point the way toward a targeted treatment for a subset of small-cell lung cancers. He showed that SCLC tumors with a specific DNA mutation are more vulnerable to certain drugs.

View story >


Brain cancer subtype caused by single gene fusion

Hutch researchers create genetically relevant model to examine the biology of supratentorial ependymomas

June 26, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Eric Holland and colleagues create a genetically relevant model to examine the biology of supratentorial ependymomas, a common brain cancer in children.

View story >


Nanoparticles take immunotherapy in new direction

Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors

May 30, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Fan Zhang has received funding from the American Brain Tumor Association to develop nanoparticles that can tackle a type of brain cancer called glioblastoma.

View story >


A focus on partnerships at Hutch/Merck summit

Research on the immune system aims to stop infectious diseases and cancer

May 11, 2018 | By Sabin Russell / Fred Hutch News Service

Article about a daylong Infectious Disease Summit hosted by Fred Hutch May 10 in Seattle.

View story >


Functional genomics provides a window into cancer's Achilles heels

Technique pinpoints unique tumor vulnerabilities — even when they are not written in tumor DNA

May 10, 2018 | By Sabrina Richards / Fred Hutch News Service

New findings by Dr. Christopher Kemp and colleagues demonstrate how functional genomics can highlight potential drug targets in patients with head and neck cancer.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.